Hosted on MSN10mon
NUS study reveals key mechanisms behind drug resistance in relapsed acute myeloid leukemiaThey also highlighted the effectiveness of a technique, called dynamic BH3 profiling (DBP), in identifying anti-cancer drugs capable of targeting relapsed leukaemia cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback